A summary of the latest developments from 12 studies in the treatment of NSCLC, gastric cancers and other solid tumors presented at ESMO 2022.
Report on treatment advances in advanced solid tumors presented at ESMO 2021.
Report on updates in the treatment of lung cancer presented at WCLC and ESMO 2021.
Report on updates in the treatment of lung and gastrointestinal cancers presented at ESMO 2021.
Dr Benjamin Besse discusses targeting other components of immune checkpoint including TIGIT, TIM-3 and OX40 in immunotherapy combinations.